NCT01366456

Brief Summary

The purpose of this study is to evaluate efficacy of Shingigu and Charcoal moxibustion scientifically and objectively.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2011

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2011

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

June 2, 2011

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 6, 2011

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2012

Completed
Last Updated

June 9, 2011

Status Verified

April 1, 2010

Enrollment Period

1 year

First QC Date

June 2, 2011

Last Update Submit

June 8, 2011

Conditions

Temperature Change

Keywords

Temperature ChangeMoxibustionWarming effect

Outcome Measures

Primary Outcomes (1)

  • Temperature Change after moxa treatment

    30 minutes after treatment

Study Arms (2)

Shingigu

ACTIVE COMPARATOR

Treat with Shingigu

Device: Moxibustion

Charcoal

ACTIVE COMPARATOR

Treat with Charcoal

Device: Moxibustion

Interventions

MoxibustionDEVICE

Comparison of different kinds of moxibustion

CharcoalShingigu

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \~65 years old

You may not qualify if:

  • Hyperthyroidism
  • Heart disease(Heart failure, angina pectoris, myocardial infarction)
  • Uncontrolled hypertension (SBP\>145mmHg or DBP\>95mmHg)
  • Severe renal disorder
  • Severe liver disorder
  • Diabetes Mellitus
  • Female are in the duration of pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Semyung University Chungju Hospital

Chungju, North Chungcheong, 380-960, South Korea

RECRUITING

MeSH Terms

Interventions

Moxibustion

Intervention Hierarchy (Ancestors)

Acupuncture TherapyComplementary TherapiesTherapeutics

Study Officials

  • Hoyeon Go, O.M.D.

    Semyung University Chungju Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Intervention Model
CROSSOVER
Sponsor Type
OTHER

Study Record Dates

First Submitted

June 2, 2011

First Posted

June 6, 2011

Study Start

June 1, 2011

Primary Completion

June 1, 2012

Study Completion

June 1, 2012

Last Updated

June 9, 2011

Record last verified: 2010-04

Locations

KR(1)